FIELD: medicine, pharmaceutics.
SUBSTANCE: what is offered is using hyaluronidase immobilised by electron-beam synthesis nanotechnology as an analgesic.
EFFECT: high analgesic activity of the declared agent (pain response inhibition - 66,5 %) more manifested than that shown by indometacin is shown.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-INFLAMMATORY AGENT | 2011 |
|
RU2458126C1 |
HYPOGLYCEMIC AGENT IN NON-INSULIN-DEPENDENT DIABETES MELLITUS | 2009 |
|
RU2416427C1 |
HEPATOPROTECTOR | 2010 |
|
RU2444569C1 |
LIFESPAN INCREASING DRUG | 2011 |
|
RU2461389C1 |
METHOD OF INCREASING STEM CELLS MOBILIZATION | 2009 |
|
RU2442601C2 |
AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
AGENT FOR INCREASING RESERVED STEM CELL NUMBER IN ORGANISM | 2009 |
|
RU2405822C1 |
HEMOSTIMULANT AND EXCITANT AND METHOD FOR HEMOPOIESIS STIMULATION | 2009 |
|
RU2414926C1 |
DRUG POSSESSING REGENERATIVE ACTIVITY | 2011 |
|
RU2480236C1 |
HAEMOSTIMULATING MEDICATION | 2010 |
|
RU2437675C1 |
Authors
Dates
2012-06-10—Published
2011-02-08—Filed